Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound

N/ACompletedNCT01208311

Northwell Health7 enrolled

Overview

The purpose of this study is to determine the amount of fibrosis in the liver of hepatitis C patients with advanced fibrosis, using endoscopic ultrasound.

Background: Transabdominal ultrasound cannot be used to quantitate fibrosis in patients with cirrhosis due to variability in the abdominal wall thickness and composition. This variability can be eliminated by using endoscopic ultrasound. Aim: To determine the amount of fibrosis in the liver of hepatitis C patients with advanced fibrosis, using endoscopic ultrasound.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Alcoholism Cirrhosis Hepatitis c

Eligibility

Sex: ALLMin age: 20 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * hepatic cirrhosis and hepatitis C and undergoing endoscopy * Alcoholic liver and undergoing endoscopy * Normal liver undergoing endoscopy Exclusion Criteria: * pregnancy * Children

Locations (1)

LIJ Medical Center- NSLIJ Health System

New Hyde Park, New York, United States

Outcomes

Primary Outcomes

Luminosity on ultrasound

Time frame: Once at the time of the endoscopic ultrasound

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.